Thermo Fisher Scientific Inc. (TMO), the leading manufacturer of innovative laboratory equipment and specialty diagnostics, recently signed an agreement to buy Alfa Aesar, a global manufacturer of research chemicals for $405 million (£256 million) in cash. The transaction is subject to customary closing conditions including regulatory approvals and is expected to be completed by the end of 2015.
A Johnson Matthey company, Alfa Aesar manufactures and supplies chemicals, metals, and life science products for research and development. Based in Heysham, U.K., it supplies over 45,000 specialty chemicals in small-scale research quantities to both industry and academic institutions. With 480 employees, the company has a global network of operations in key research hubs in the United States, Germany, China, South Korea and India.
The acquisition is expected to complement Thermo Fisher’s product market to a great extent.
Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific, says, “The acquisition of Alfa Aesar enhances our existing portfolio of chemicals, solvents and reagents to support virtually every laboratory application – from research, to drug discovery and development, to production. In addition, customers will benefit from greater access to these products through our extensive global commercial reach.”
Thermo Fisher is a reliable provider of top quality centrifuges, histology equipment, and chemistry reagents, controls and consumables. With revenues of $17 billion and approximately 50,000 employees in 50 countries, the company’s mission is to enable their customers to make the world healthier, cleaner and safer.